Showing results (91-100 of 121) with videos related to
Sort By:
Pageof 13
International Journal of Oncology|October 9, 2002
Monitoring expression of HER-2 on circulating epithelial cells in patients with advanced breast cancerD F Hayes, T M Walker, B Singh, et al.Clinical Pharmacology and Therapeutics|September 10, 2010
Estrogen receptor genotypes, menopausal status, and the effects of tamoxifen on lipid levels: revised and updated resultsD F Hayes, T C Skaar, J M Rae, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 25, 2013
Predictors of recovery of ovarian function during aromatase inhibitor therapyN L Henry, R Xia, M Banerjee, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1991
Prediction of prognosis in primary breast cancer by detection of a high molecular weight mucin-like antigen using monoclonal antibodies DF3, F36/22, and CU18: a Cancer and Leukemia Group B studyD F Hayes, R Mesa-Tejada, L D Papsidero, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 11, 1992
Tsukamurella paurometabolum: a novel pathogen causing catheter-related bacteremia in patients with cancerC L Shapiro, R F Haft, N M Gantz, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1995
Randomized comparison of tamoxifen and two separate doses of toremifene in postmenopausal patients with metastatic breast cancerD F Hayes, J A Van Zyl, A Hacking, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 1998
Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatmentM D Pegram, A Lipton, D F Hayes, et al.British Journal of Cancer|July 8, 2010
Inflammatory cytokines and aromatase inhibitor-associated musculoskeletal syndrome: a case-control studyN L Henry, D Pchejetski, R A'Hern, et al.The Journal of Experimental Medicine|June 1, 1996
Recombinant human stem cell factor (kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivoJ J Costa, G D Demetri, T J Harrist, et al.European Journal of Cancer (Oxford, England : 1990)|February 18, 2011
Zoledronic acid preserves bone mineral density in premenopausal women who develop ovarian failure due to adjuvant chemotherapy: final results from CALGB trial 79809C L Shapiro, S Halabi, V Hars, et al.Pageof 13